Table 3 Univariate and multivariate survival analysis
From: Clinical significance of visual cardiac 18F-FDG uptake in advanced non-small cell lung cancer
Different variables | PFS | OS | |||||
|---|---|---|---|---|---|---|---|
Univariate | Univariate | Multivariate | |||||
MST (days) | p-value | MST (days) | p-value | HR (95%CI) | p-value | ||
Age | < 70y ≧70y | 189 209 | 0.701 | NR 474.5 | 0.288 | ||
Gender | Male Female | 189 240 | 0.529 | 449 NR | 0.074 | ||
PS | 0–1 2–3 | 209 315 | 0.780 | 560 342 | 0.513 | ||
Histology | AC Others | 276 137 | 0.174 | NR 234 | 0.023 | 1.372 (0.524–3.591) | 0.523 |
NLR | High Low | 150 210 | 0.545 | 296 NR | 0.007 | 2.745 (1.049–7.179) | 0.032 |
PLR | High Low | 165 282 | 0.844 | 559 549 | 0.955 | ||
PNI | High Low | 240 178 | 0.701 | 560 449 | 0.494 | ||
GPS | 0 1–2 | 270 145 | 0.107 | NR 306 | 0.008 | 2.392 (0.916–6.245) | 0.075 |
BMI | High Low | 208 225 | 0.432 | 523 NR | 0.414 | ||
Cachexia | Yes No | 180 239 | 0.198 | 418 717 | 0.306 | ||
Cardiac FDG (visual) | High Low | 268 165 | 0.196 | NR 363 | 0.045 | 0.144 (0.024–0.855) | 0.060 |
Cardiac SUVmax | High Low | 308 178 | 0.101 | NR 378 | 0.015 | 0.088 (0.013–0.584) | 0.028 |
Tumor SUVmax | High Low | 178 210 | 0.753 | 699 49 | 0.677 | ||
Tumor MTV | High low | 151 347 | 0.433 | 307 NR | 0.112 | ||
Tumor TLG | High Low | 149 427 | 0.196 | 247 NR | 0.019 | 1.529 (0.563–4.149) | 0.401 |
First-line regimen | ICI Non-ICI | 182 270 | 0.742 | 781 418 | 0.350 | ||